Viral DNA that is usually dismissed when sequencing the human genome could help to uncover useful information about complex ...
The Company's ATM financing vehicle allows the Company to sell its common stock directly into the trading market at market price. The amount raised through our ATM for 2025 exceeded the Company's 2025 ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Greenwich's $3.81 million cash position covers less than two months of operations, making near-term financing highly likely ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Six years after registering, an Indian army soldier donated stem cells to save a blood cancer patient. Highlighted by DKMS ...
The process by which glycoRNAs are created and deployed to the cell surface has been identified by Boston Children’s Hospital researchers.
DKMS Foundation has emphasized the critical importance of blood stem cell donation, describing it as a lifeline for patients battling life-threatening blood cancers and disorders. With patients ...
Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.
For years, gluten has been cast as the villain in our modern diet. Walk into any grocery store and you'll see entire aisles ...